Caroline L Ashley

Nuclear domain 10 components upregulated via interferon during human cytomegalovirus infection potently regulate viral infection.

M. Glass, B. McSharry, B. Slobedman, 2017, The Journal of general virology.

Assessing the suitability of long non-coding RNAs as therapeutic targets and biomarkers in SARS-CoV-2 infection

S. Ataide, M. Steain, Caroline L Ashley, 2022, Frontiers in Molecular Biosciences.

Mucosal TLR2-activating protein-based vaccination induces potent pulmonary immunity and protection against SARS-CoV-2 in mice

J. Mackay, S. Turville, W. Britton, 2022, Nature Communications.

High-Titer Neutralizing Antibodies against the SARS-CoV-2 Delta Variant Induced by Alhydroxyquim-II-Adjuvanted Trimeric Spike Antigens

F. Wurm, Maria J. Wurm, N. Landau, 2022, Microbiology spectrum.

Neutralising antibodies against the SARS-CoV-2 Delta variant induced by Alhydroxyquim-II-adjuvanted trimeric spike antigens

F. Wurm, Maria J. Wurm, N. Landau, 2021, bioRxiv.

Virus-Mediated Suppression of the Antigen Presentation Molecule MR1

J. McCluskey, J. Rossjohn, D. Fairlie, 2020, Cell reports.

Mucosal immunization with a delta-inulin adjuvanted recombinant spike vaccine elicits lung-resident immune memory and protects mice against SARS-CoV-2

N. Petrovsky, W. Britton, P. Hansbro, 2022, Mucosal Immunology.